A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fed Conditions

NCT00865462 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Abrika Bupropion 150 mg XL Tablet, single dose
DRUG: Wellbutrin XL® 150 mg Tablet, single dose

Sponsor

Actavis Inc.